Prescribe+ Launches The Specialty Summit USA to Advance Multi-Specialty Medication Access Solutions

Multi-Specialty Medication Access Summit Premieres May 26–29, 2026 in Nashville

CHARLOTTE, NC, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Prescribe+, a leader in strategic access and commercialization solutions, today announces the The Specialty Summit USA, a first-of-its-kind series of advisory-style summits designed to break down barriers to specialty medication access across 11 therapeutic areas. The debut event will be held May 26–29, 2026, in Nashville, Tennessee.

The Specialty Summit USA convenes senior executives and front-line experts from biopharma, specialty pharmacy, technology, advocacy, and care delivery to:
• Co-create solutions that accelerate patient support
• Share field-validated insights for access strategies and product planning
• Align cross-functional teams on real-time challenges

11 Focused Summits, One Unified Mission

Each tailored summit delivers deep dives and cross-stakeholder collaboration in:
• Allergy & Immunology
• Cell & Gene Therapy
• Dermatology
• Gastroenterology
• Hematology
• Infectious Disease
• Neurology
• Oncology
• Rare Disease
• Retina
• Rheumatology

Agenda Highlights
• Advisory roundtables by therapeutic area to surface front-line barriers
• Strategic panels featuring payer, provider, manufacturer, and tech experts
• Patient Services Innovation Lab exploring affordability, HUB models, and adherence
• Digital Access Showcase of cutting-edge platforms and automation tools
• Networking receptions, executive roundtables, and Partner Expo for high-value connections

“In today’s landscape, speed, precision, and patient outcomes matter more than ever,” said Elizabeth Johnson, Co-CEO of Prescribe+. “The Specialty Summit USA delivers actionable insights that industry leaders can apply immediately to enhance access strategies and cross-functional alignment.”

“We are creating an insight-rich forum where patient access challenges become solving strategies—driven by the very providers, medication access and biologics coordinators, pharmacists, and advocates who live them every day,” added Melissa Paige, Co-CEO of Prescribe+.

Who Should Attend
Commercial & Access Leadership
• Vice Presidents and Directors of Market Access
• Managed Markets and Reimbursement Strategy Executives
• Commercial Operations and Field Deployment Leaders
• Franchise Heads and Brand Directors by Therapeutic Area
• Business Development and Strategic Partnerships Leaders

Patient Services & HUB Operations
• Patient Access Services Executives
• HUB Program Directors and Managers
• Co-Pay and Affordability Strategy Leaders
• Specialty Pharmacy Integration Managers

Medical & Clinical Affairs
• Medical Affairs Directors and Field MSL Leads
• Clinical Development and Investigator Relations Teams
• Scientific Communications and Evidence Generation Leaders

HEOR & Value Demonstration
• HEOR (Health Economics & Outcomes Research) Executives
• RWE (Real-World Evidence) and Outcomes Analytics Directors
• Payer Evidence & Value Communication Leads

Policy & Advocacy
• Government Affairs and Public Policy Executives
• Advocacy Relations Directors
• Public-Private Partnership Development Leaders

Specialty Drug Channel Strategy
• Trade and Distribution Executives
• Specialty Pharmacy Relations Managers
• Digital Therapeutics and Telehealth Commercial Teams

Solution & Service Providers
Specialty Pharmacies
Non-Profit Foundations

Next Up: 2026 Strategic Reveal – Las Vegas, April 29, 2025
Prescribe+ will host an exclusive Strategic Reveal in Las Vegas on April 29, 2025, unveiling expanded formats, insights, and early partnership opportunities for the 2026 portfolio.

Registration & Sponsorship Opportunities
Sponsorship packages and speaker opportunities will be announced soon. Stay tuned for the upcoming registration launch, which will include discounted rates for advocacy organizations and care professionals.

Learn more at:
www.specialtysummitusa.com
________________________________________
About Prescribe+
Prescribe+ is a strategic advisory firm advancing medication access and patient service programs through tailored insights, innovation-driven collaboration, and real-world experience. From field reimbursement to patient support optimization, Prescribe+ helps stakeholders dismantle barriers to care and improve patient outcomes across the healthcare landscape. As host of the Healthcare Advocate Summit and Specialty Summit USA, they unite stakeholders to co-create real-world solutions.

Melissa Paige, Co-CEO
Prescribe+
email us here
Visit us on social media:
LinkedIn